Xiaohuan Wang Selected Research

Erythromycin Estolate (Ilosone)

11/2019

Erythromycin Estolate Inhibits Zika Virus Infection by Blocking Viral Entry as a Viral Inactivator.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaohuan Wang Research Topics

Disease

6	Infections 01/2022 - 01/2016
2	Myocardial Infarction 01/2022 - 11/2009
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 12/2021
2	Zika Virus Infection 11/2019 - 01/2019
2	Trichinellosis 11/2016 - 11/2016
1	Coronavirus Infections 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Infarction (Infarctions) 01/2022
1	Pathologic Processes 01/2022
1	Ischemia 12/2021
1	Vasculitis (Vasculitides) 01/2021
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Transfusion Reaction 01/2021
1	Neoplasms (Cancer) 01/2019
1	Lymphoma (Lymphomas) 01/2019
1	Experimental Arthritis 01/2018
1	Arthritis (Polyarthritis) 01/2018
1	Communicable Diseases (Infectious Diseases) 12/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2016
1	Inflammation (Inflammations) 11/2016
1	Body Weight (Weight, Body) 02/2015
1	Dehydration (Water Stress) 10/2013
1	Down Syndrome (Down's Syndrome) 04/2013
1	ST Elevation Myocardial Infarction 11/2009

Drug/Important Bio-Agent (IBA)

6	VaccinesIBA 11/2019 - 01/2016
2	montelukast (Singulair)FDA Link 01/2022 - 01/2019
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2022 - 12/2021
2	Pharmaceutical PreparationsIBA 01/2022 - 11/2019
2	Shen-FuIBA 01/2022 - 12/2021
2	Proteins (Proteins, Gene)FDA Link 05/2016 - 02/2015
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Membrane LipidsIBA 01/2022
1	Adenosine Monophosphate (AMP)IBA 01/2022
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2022
1	Nicorandil (SG 75)IBA 01/2022
1	LigandsIBA 01/2022
1	InflammasomesIBA 01/2021
1	NLR ProteinsIBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2019
1	Erythromycin Estolate (Ilosone)FDA Link 11/2019
1	MacrolidesIBA 11/2019
1	Antiviral Agents (Antivirals)IBA 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019
1	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 01/2019
1	Collagen Type II (Type II Collagen)IBA 01/2018
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 11/2016
1	Subunit VaccinesIBA 11/2016
1	TropomyosinIBA 11/2016
1	EpitopesIBA 11/2016
1	4- chloro- N- (2- ((5- trifluoromethyl- 2- pyridyl)sulfonyl)ethyl)benzamideIBA 11/2016
1	Imiquimod (Aldara)FDA LinkGeneric 11/2016
1	Peptide Hydrolases (Proteases)FDA Link 05/2016
1	Protease Inhibitors (Protease Inhibitor)IBA 05/2016
1	Recombinant ProteinsIBA 01/2016
1	A-Form DNA (A-DNA)IBA 01/2016
1	SolutionsIBA 02/2015
1	Silk FDA Link 02/2015
1	ElementsIBA 10/2013
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2013

Therapy/Procedure

1	Ischemic Postconditioning 12/2021
1	Blood Transfusion (Blood Transfusions) 01/2021
1	Immunomodulation 01/2018
1	Therapeutics 12/2017
1	Percutaneous Coronary Intervention 11/2009